Research Indicates DNA Contamination in Pfizer Covid-19 Vaccines
A recent study asserts that the levels of DNA contamination in Pfizer's Covid-19 vaccines surpass regulatory safety thresholds by as much as 470 times. Read Full Article at RT.com.
TroibNews 
Experts are raising alarms about the possibility that genetic fragments in vaccines could overstimulate the immune system, leading to an increased cancer risk.
A peer-reviewed study published this week in the Journal of High School Science claims that Pfizer’s mRNA Covid-19 vaccines contain levels of residual DNA that exceed regulatory safety limits. The research was conducted by student scientists at the US Food and Drug Administration’s White Oak Campus lab in Maryland.
Residual DNA refers to small segments of genetic material that may linger in vaccines or medications post-manufacturing. These fragments originate from the cells or processes used in the production of these products.
According to guidelines set forth by the World Health Organization, a single vaccine dose should not exceed 10 nanograms of residual DNA. However, this study discovered that levels in Pfizer’s vaccines surpass this threshold by six to 470 times.
The researchers analyzed vaccines sourced from BEI Resources, a supplier associated with the National Institute of Allergy and Infectious Diseases, employing NanoDrop and Qubit methods to assess DNA levels. Both techniques indicated contamination beyond acceptable limits, with residual DNA detected in six vials across two different vaccine lots.
While the study acknowledged that the health risks linked to these DNA fragments are “currently unknown,” the researchers cautioned that, theoretically, these fragments could integrate into human DNA and elevate the risk of gene mutations. They also expressed concerns about the presence of oncogenes within these fragments, which could potentially lead to cancer. The authors urged for further investigation to explore these potential risks.
The FDA has not yet responded to the study's findings. Although concerns regarding DNA contamination in Covid-19 vaccines have circulated for years, US regulatory authorities have consistently dismissed such claims, affirming that they do not pose health risks.
Kevin McKernan, founder of Medicinal Genomics, labeled the findings a “bombshell,” cautioning that DNA fragments might overstimulate the immune system, possibly “fueling cancer growth.” In an interview with Maryanne Demasi, an investigative journalist from Australia who first highlighted the study, McKernan stated, “Repeated exposure to foreign DNA through Covid-19 boosters may amplify this risk over time, creating conditions conducive to cancer development.”
Nikolai Petrovsky, a professor of immunology and head of Vaxine, an Australian biotechnology company, characterized the findings as a “smoking gun” and emphasized the need for immediate regulatory scrutiny. Petrovsky further accused the FDA of withholding crucial information from the public, asserting that the study “clearly shows the FDA was aware of these data,” as it was carried out in its own lab under its scientists' supervision.
Sophie Wagner for TROIB News
A peer-reviewed study published this week in the Journal of High School Science claims that Pfizer’s mRNA Covid-19 vaccines contain levels of residual DNA that exceed regulatory safety limits. The research was conducted by student scientists at the US Food and Drug Administration’s White Oak Campus lab in Maryland.
Residual DNA refers to small segments of genetic material that may linger in vaccines or medications post-manufacturing. These fragments originate from the cells or processes used in the production of these products.
According to guidelines set forth by the World Health Organization, a single vaccine dose should not exceed 10 nanograms of residual DNA. However, this study discovered that levels in Pfizer’s vaccines surpass this threshold by six to 470 times.
The researchers analyzed vaccines sourced from BEI Resources, a supplier associated with the National Institute of Allergy and Infectious Diseases, employing NanoDrop and Qubit methods to assess DNA levels. Both techniques indicated contamination beyond acceptable limits, with residual DNA detected in six vials across two different vaccine lots.
While the study acknowledged that the health risks linked to these DNA fragments are “currently unknown,” the researchers cautioned that, theoretically, these fragments could integrate into human DNA and elevate the risk of gene mutations. They also expressed concerns about the presence of oncogenes within these fragments, which could potentially lead to cancer. The authors urged for further investigation to explore these potential risks.
The FDA has not yet responded to the study's findings. Although concerns regarding DNA contamination in Covid-19 vaccines have circulated for years, US regulatory authorities have consistently dismissed such claims, affirming that they do not pose health risks.
Kevin McKernan, founder of Medicinal Genomics, labeled the findings a “bombshell,” cautioning that DNA fragments might overstimulate the immune system, possibly “fueling cancer growth.” In an interview with Maryanne Demasi, an investigative journalist from Australia who first highlighted the study, McKernan stated, “Repeated exposure to foreign DNA through Covid-19 boosters may amplify this risk over time, creating conditions conducive to cancer development.”
Nikolai Petrovsky, a professor of immunology and head of Vaxine, an Australian biotechnology company, characterized the findings as a “smoking gun” and emphasized the need for immediate regulatory scrutiny. Petrovsky further accused the FDA of withholding crucial information from the public, asserting that the study “clearly shows the FDA was aware of these data,” as it was carried out in its own lab under its scientists' supervision.
Sophie Wagner for TROIB News
